The implementation of clinical needs and feedback throughout the development cycle of wearable health-monitoring technology is key to success. Close collaboration with all stakeholders involved will speed clinical translation to the market.
This is a preview of subscription content, access via your institution
References
-
Brasier, N. et al. Nature 636, 57–68 (2024).
-
Eskerod, P., Huemann, M. & Savage, G. Proj. Manag. J. 46, 6–14 (2015).
-
Austin, C. P. Nat. Rev. Drug Discov. 17, 455–456 (2018).
-
Smuck, M., Odonkor, C. A., Wilt, J. K., Schmidt, N. & Swiernik, M. A. npj Digital Med. 4, 45 (2021).
-
Jacob, C. et al. npj Digital Med. 6, 232 (2023).
-
Santos, G. & Jones, M. W. Prevention of Surgical Errors (StatPearls, 2023).
-
Anderson, O., Davis, R., Hanna, G. B. & Vincent, C. A. Am. J. Surg. 206, 253–262 (2013).
-
Staiger, R. D. et al. Ann. Surg. 268, 784–791 (2018).
-
Hollis, R. H. et al. Ann. Surg. 263, 918–923 (2016).
-
Liu, J. et al. Science 383, 1096–1103 (2024).
-
Domenghino, A. et al. Nat. Med. 29, 811–822 (2023).
-
Chung, H. U. et al. Science 363, eaau0780 (2019).
-
Brasier, N. et al. Cell Biomater. 1, 100014 (2025).
-
Xu, S., Kim, J., Walter, J. R., Ghaffari, R. & Rogers, J. A. Sci. Transl. Med. 14, eabn6036 (2022).
-
Tu, J. et al. Nat. Biomed. Eng. 7, 1293–1306 (2023).
Acknowledgements
N.B. would like to acknowledge an Early-career Fellowship by Collegium Helveticum, Zurich, Switzerland.
Ethics declarations
Competing interests
S.X. is the co-founder and CEO of a private medical technology company developing wearable devices. N.B., A.D., C.A.M., C.J. and J.A.R. declare no competing interests.
Rights and permissions
About this article
Cite this article
Brasier, N., Domenghino, A., Meier, C.A. et al. Implementing clinical needs into the development of wearable health-monitoring technology. Nat. Nanotechnol. (2025). https://doi.org/10.1038/s41565-025-02020-0
-
Published:
-
DOI: https://doi.org/10.1038/s41565-025-02020-0
